Help or hindrance? Rituximab maintenance and COVID

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2024-09-12
DOI
https://doi.org/10.3324/haematol.2024.286142
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Help or hindrance? Rituximab maintenance and COVID

Ariela Noy
Haematologica
SARS-CoV-2 and COVID-19 Research
article

Help or hindrance? Rituximab maintenance and COVID

Ariela Noy
article en

Abstract

No abstract available for this paper.
HaematologicaVol. 110(1)
Memorial Sloan Kettering Cancer Center (US), Cornell University (US)
Openalex Percentile: Top 81%
SARS-CoV-2 and COVID-19 Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Help or hindrance? Rituximab maintenance and COVID — Ariela Noy · Haematologica (2024) | TGRS Research Map | TGRS